An Epidemiological Registry Study to Evaluate Clinical Practice Treatment in Patients With Bipolar Disorder

NCT01455961 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 16000

Last updated 2014-08-21

No results posted yet for this study

Summary

The aim of this study is to describe the treatment pattern and patient characteristics in real life setting in patients with Bipolar disorder treated with Seroquel XR and/or Seroquel IR in Sweden.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Andreas Carlborg, MD · Department of Clinical Neuroscience, Karolinska Institutet 171 76 Stockholm

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2012-04-30
Completion
2012-04-30

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01455961 on ClinicalTrials.gov